The COVID-19 (SARS-CoV-2) Antigen Rapid Test Kit, developed by GAOBEIDIAN PRISES BIOTECHNOLOGY CO., LTD, represents a critical advancement in the fight against the global pandemic. This article provides an in-depth analysis of its principle, features, components, technical specifications, applications, and the company background. By leveraging cutting-edge technology and rigorous validation, this test kit offers a reliable, user-friendly solution for rapid diagnosis of SARS-CoV-2 infections.
The COVID-19 Antigen Test Kit employs immunochromatography, a widely used method for rapid diagnostic testing. This technique relies on the specific interaction between antibodies and antigens to detect the presence of the virus. The test strip comprises two key components:
When a sample (e.g., nasal or oropharyngeal swab) is applied to the test strip, the antigen present in the sample binds to the monoclonal antibody on the conjugate pad. This complex then migrates along the membrane, where it interacts with the T line. If the antigen is present, a visible line appears at the T position, indicating a positive result. The C line serves as a control to confirm the test's validity.


The COVID-19 Antigen Rapid Test Kit is designed to meet the demands of both healthcare professionals and the general public. Its standout features include:
The COVID-19 Antigen Test Kit includes the following components, ensuring a comprehensive testing experience:
| Product Name | COVID-19 (SARS-CoV-2) Antigen Rapid Test Kit |
|---|---|
| Brand Name | GOLDEN TIME |
| Methodology | Colloidal Gold |
| Specimen | Nasal swab, oropharyngeal swab, or nasopharyngeal swab |
| Clinical Sensitivity | 96.330% |
| Clinical Specificity | 99.569% |
| Overall Agreement | 98.79% |
| Packing | 1/5/20 tests/carton, according to customer requirements |
| Reading Time | 10 minutes |
| Service Support | OEM/ODM |
The COVID-19 Antigen Rapid Test Kit is designed for use in a variety of settings, including:
It is important to note that while the test provides preliminary results, confirmation with PCR testing is recommended for definitive diagnosis. The results should be interpreted in conjunction with clinical findings and the professional judgment of healthcare providers.
GAOBEIDIAN PRISES BIOTECHNOLOGY CO., LTD is a leading manufacturer of diagnostic products, dedicated to developing innovative solutions for global health challenges. With a commitment to quality and precision, the company has established itself as a trusted name in the field of medical diagnostics. Their expertise in immunochromatography and rapid diagnostic testing has enabled the creation of the COVID-19 Antigen Rapid Test Kit, which combines cutting-edge technology with user-friendly design.
The company's OEM/ODM service allows for customization to meet the specific needs of clients, ensuring that the products are tailored to different market requirements. This flexibility, combined with their rigorous quality control processes, ensures that their products meet the highest standards of reliability and performance.
For more information about GAOBEIDIAN PRISES BIOTECHNOLOGY CO., LTD, visit their official website.
The COVID-19 (SARS-CoV-2) Antigen Rapid Test Kit is a vital tool in the ongoing effort to combat the pandemic. Its combination of speed, accuracy, and ease of use makes it an essential resource for healthcare providers and the general public alike. By leveraging the latest advancements in immunochromatography, this test kit offers a reliable solution for rapid diagnosis, contributing to effective disease management and public health strategies.
For further information on the technical standards and regulatory guidelines related to rapid diagnostic tests, the National Institute of Standards and Technology (NIST) provides valuable resources. NIST's research and development efforts in metrology and standards play a crucial role in ensuring the accuracy and reliability of diagnostic technologies.
[1] National Institute of Standards and Technology (NIST). "Standards for Medical Devices and Diagnostic Testing." Retrieved from https://www.nist.gov.